Home / Ceftriaxone / United States
US ATC J01DD04 · updated 3 Nov 2026
Ceftriaxone shortage in United States
Is there a Ceftriaxone shortage in United States?
Yes. As of 3 Nov 2026, 2 Ceftriaxone products are reported short in United States, the first since 30 Oct 2026. No return date has been given. Main reason: not stated.
Also short in Italy, Spain, Belgium, Czechia, Japan. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Ceftriaxone Sodium in Plastic Container, Injection, 1g/50mL (NDC 0338-5002-41) discontinuation | Baxter Healthcare | 30 Oct 2026 | not given | Not stated |
| US | Ceftriaxone Sodium in Plastic Container, Injection, 2g/100 mL (NDC 0338-5003-41) discontinuation | Baxter Healthcare | 30 Oct 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).